Beam
Jeffrey Wong currently serves as a Senior Research Associate at Beam Therapeutics, specializing in antibody discovery and engineering since February 2022. Prior experience includes roles as a Senior Research Associate at Elpis Biopharmaceuticals from 2020 to 2022, an Associate Scientist at NovaRock Biotherapeutics Ltd from 2019 to 2020, and a Research Associate at Princeton BioMeditech Corporation from 2018 to 2019. Jeffrey Wong holds a Bachelor's degree in Biology/Biological Sciences from the University at Buffalo.
Beam
10 followers
Beam Therapeutics, launched in 2018, is pioneering the use of CRISPR base editing to develop a broad portfolio of advanced genetic medicines.